LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

Search

Zoetis Inc

Closed

SectorHealthcare

76.68 0.07

Overview

Share price change

24h

Current

Min

75

Max

78.63

Key metrics

By Trading Economics

Income

-2M

601M

Sales

-125M

2.3B

P/E

Sector Avg

12.569

51.415

EPS

1.53

Dividend yield

2.45

Profit margin

26.569

Employees

14,500

EBITDA

-6M

941M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+77.81% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.45%

2.34%

Next Earnings

4 sie 2026

Next Dividend date

2 cze 2026

Next Ex Dividend date

17 lip 2026

Market Stats

By TradingEconomics

Market Cap

-15B

32B

Previous open

76.61

Previous close

76.68

News Sentiment

By Acuity

54%

46%

269 / 346 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Zoetis Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 sie 2025, 11:06 UTC

Earnings

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 sie 2025, 11:06 UTC

Earnings

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 sie 2025, 11:05 UTC

Earnings

Zoetis 2Q Adj EPS $1.76 >ZTS

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

77.81% upside

12 Months Forecast

Average 136.33 USD  77.81%

High 160 USD

Low 99 USD

Based on 14 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

8

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

152.58 / N/ASupport & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

269 / 346 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat